By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

PhaseRx 



Seattle  Washington    U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





Company News
PhaseRx (PZRX) Receives Orphan Drug Designation From FDA For PRX-OTC For The Treatment Of Ornithine Transcarbamylase Deficiency 11/28/2016 6:55:16 AM
PhaseRx (PZRX) Announces Positive Safety Results From Large Animal Study With Hybrid mRNA Delivery Technology 11/9/2016 12:03:39 PM
PhaseRx (PZRX) Reports Third Quarter 2016 Financial Results And Provides Corporate Update 11/8/2016 11:28:18 AM
PhaseRx (PZRX) To Present Company Overview At Upcoming Investor Conferences 10/11/2016 10:19:58 AM
PhaseRx (PZRX) To Present At The 2016 Aegis Growth Conference 9/14/2016 10:11:58 AM
PhaseRx (PZRX) Appoints Peggy Phillips To Board Of Directors 8/23/2016 8:25:27 AM
PhaseRx (PZRX) Reports Second Quarter 2016 Financial Results And Provides Corporate Update 8/3/2016 7:18:17 AM
PhaseRx (PZRX) Appoints Gordon Brandt, M.D. As Chief Medical Officer 7/20/2016 6:36:09 AM
PhaseRx (PZRX) Announces Targeted mRNA Data Presentations At The Controlled Release Society Annual Meeting And Exposition 7/11/2016 7:47:52 AM
PhaseRx (PZRX) Advances Product Pipeline For Treatment Of Rare Genetic Liver Diseases 6/21/2016 6:29:40 AM
12
//-->